Protionamide

This classification denotes an antitubercular agent with the molecular formula C9H12N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76YOO33643, chemically known as 4-pyridinecarbothioamide, 2-propyl- (9ci) but generally known as protionamide, which bears US NIH Compound Identifier 666418. European Medicines Agency schedules Protionamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10141MIG. The term PROTIONAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules protionamide in its Anatomical Therapeutic Chemical (ATC) Classification. PROTIONAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule protionamide under HS 29333999 and SITC 51574. As of Q4 2014, PROTIONAMIDE remains the US FDA Preferred Term for this commodity. Protionamide bears US NLM identifiers UMLS ID C0033705 and NCI Concept Code C72605. SMILES: S=C(N)C1CC(NCC1)CCC.